AstraZeneca said on Thursday it would build a cell therapy ​manufacturing and supply base and an innovation centre ‌in Shanghai, aiming to become the first global drugmaker with end-to-end cell ...
In China’s second-largest city, historic architecture finds new life as galleries and dining destinations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results